The DOI matches its Crossref record.
Xenografted Adult Human Mesenchymal Stem Cells Provide a Platform for Sustained Biological Pacemaker Function in Canine Heart
Open accessAbstract
Background— Biological pacemaking has been performed with viral vectors, human embryonic stem cells, and adult human mesenchymal stem cells (hMSCs) as delivery systems. Only with human embryonic stem cells are data available regarding stability for >2 to 3 weeks, and here, immunosuppression has been used to facilitate survival of xenografts. The purpose of the present study was to determine whether hMSCs provide stable impulse initiation over 6 weeks without the use of immunosuppression, the “dose” of hMSCs that ensures function over this period, and the catecholamine responsiveness of hMSC-packaged pacemakers. Methods and Results— A full-length mHCN2 cDNA subcloned in a pIRES2-EGFP vector was electroporated into hMSCs. Transfection efficiency was estimated by GFP expression. I HCN2 was measured with patch clamp, and cells were administered into the left ventricular anterior wall of adult dogs in complete heart block and with backup electronic pacemakers. Studies encompassed 6 weeks. I HCN2 for all cells was 32.1±1.3 pA/pF (mean±SE) at −150 mV. Pacemaker function in intact dogs required 10 to 12 days to fully stabilize and persisted consistently through day 42 in dogs receiving ≥700 000 hMSCs (≈40% of which carried current). Rhythms were catecholamine responsive. Tissues from animals killed at 42 days manifested neither apoptosis nor humoral or cellular rejection. Conclusions— hMSCs provide a means for administering catecholamine-responsive biological pacemakers that function stably for 6 weeks and manifest no cellular or humoral rejection at that time. Cell doses >700 000 are sufficient for pacemaking when administered to left ventricular myocardium.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Use of Mesenchymal Stem Cells for Therapy of Cardiac Disease
Karantalis, V., & Hare, J. M. (2015) · Circulation Research · doi:10.1161/circresaha.116.303614 · Cited by 425
Early afterdepolarizations and cardiac arrhythmias
Weiss, J. N., Garfinkel, A., Karagueuzian, H. S., Chen, P.-S., & Qu, Z. (2010) · Heart Rhythm · doi:10.1016/j.hrthm.2010.09.017 · Cited by 396
Golpanian, S., Wolf, A., Hatzistergos, K. E., & Hare, J. M. (2016) · Physiological Reviews · doi:10.1152/physrev.00019.2015 · Cited by 343
Cardiac fibrosis and arrhythmogenesis: The road to repair is paved with perils
Nguyen, T. P., Qu, Z., & Weiss, J. N. (2014) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2013.10.018 · Cited by 335
Concise Review: Mesenchymal Stromal Cells: Potential for Cardiovascular Repair
Psaltis, P. J., Zannettino, A. C. W., Worthley, S. G., & Gronthos, S. (2008) · Stem Cells · doi:10.1634/stemcells.2008-0428 · Cited by 303
Metadata
- Authors
- Plotnikov, A. N., Shlapakova, I., Szabolcs, M. J., Danilo, P., Lorell, B. H., Potapova, I. A., Lu, Z., Rosen, A. B., Mathias, R. T., Brink, P. R., Robinson, R. B., Cohen, I. S., & Rosen, M. R.
- Venue
- Circulation
- Published
- 2007-08-14
- Volume
- 116
- Issue
- 7
- Pages
- 706-713
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2096890594
- Cited by
- 191
- References
- 0
- FWCI
- 6.21
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Xenografted Adult Human Mesenchymal Stem Cells Provide a Platform for Sustained Biological Pacemaker Function in Canine Heart. https://app.cochat.ai/papers/10.1161/circulationaha.107.703231
- The paper
- Plotnikov, A. N., Shlapakova, I., Szabolcs, M. J., Danilo, P., Lorell, B. H., Potapova, I. A., Lu, Z., Rosen, A. B., Mathias, R. T., Brink, P. R., Robinson, R. B., Cohen, I. S., & Rosen, M. R. (2007). Xenografted Adult Human Mesenchymal Stem Cells Provide a Platform for Sustained Biological Pacemaker Function in Canine Heart. Circulation. https://doi.org/10.1161/circulationaha.107.703231
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.